Press Release / May 25, 2017
Hovione Announces Start of Phase 1 Clinical Trial of HY02
HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation
Pharma's Almanac, Q2 2017, June, 2017
Hovione became a Certified B Corp at the B Corp Summer Summit 2017, in Cascais, Portugal
National Science and Technology Meeting, Science 2017, in Lisbon, Portugal
Irish Examiner, 7 Jul 2017
ONdrugDelivery, April, 2017
Hovione New Jersey welcomes a team of 8 FDA Reviewers for a training on Quality by Design (QbD)
Healthcare Packaging, September 12, 2017